Value through Innovation27 July 2016

Clinical Study Results

  • VARGATEF ® - Genital Neoplasms, Female
    Clinical Study Number 1199.6
    Study Indication Genital Neoplasms, Female
    Product VARGATEF ®
    Generic Name Nintedanib
    Lab Code
    Clinical Phase I
    Study Title

    Phase I trial of escalating doses of BIBF 1120 in combination with paclitaxel/carboplatin in patients with advanced gynaecological malignancies

    Study Document Trial synopsis 1199.6 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.